大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/02/22 | 5,584 | 5,678 | 5,580 | 5,638 | +42 | +0.8% | 995,400 |
2024/02/21 | 5,559 | 5,623 | 5,542 | 5,596 | +37 | +0.7% | 993,400 |
2024/02/20 | 5,527 | 5,625 | 5,506 | 5,559 | +47 | +0.9% | 862,000 |
2024/02/19 | 5,574 | 5,624 | 5,495 | 5,512 | -90 | -1.6% | 806,200 |
2024/02/16 | 5,482 | 5,661 | 5,482 | 5,602 | +174 | +3.2% | 1,735,600 |
2024/02/15 | 5,440 | 5,506 | 5,338 | 5,428 | -6 | -0.1% | 2,480,200 |
2024/02/14 | 5,410 | 5,614 | 5,261 | 5,434 | +75 | +1.4% | 3,347,500 |
2024/02/13 | 5,044 | 5,359 | 5,030 | 5,359 | -285 | -5% | 3,274,800 |
2024/02/09 | 5,646 | 5,777 | 5,623 | 5,644 | -14 | -0.2% | 1,397,900 |
2024/02/08 | 5,621 | 5,689 | 5,577 | 5,658 | +28 | +0.5% | 1,045,900 |
2024/02/07 | 5,635 | 5,707 | 5,583 | 5,630 | -46 | -0.8% | 850,100 |
2024/02/06 | 5,694 | 5,745 | 5,642 | 5,676 | -65 | -1.1% | 870,900 |
2024/02/05 | 5,695 | 5,764 | 5,689 | 5,741 | +53 | +0.9% | 578,200 |
2024/02/02 | 5,761 | 5,779 | 5,685 | 5,688 | -49 | -0.9% | 703,200 |
2024/02/01 | 5,801 | 5,815 | 5,733 | 5,737 | -87 | -1.5% | 591,400 |
2024/01/31 | 5,699 | 5,824 | 5,690 | 5,824 | +49 | +0.8% | 916,100 |
2024/01/30 | 5,855 | 5,855 | 5,757 | 5,775 | -65 | -1.1% | 854,300 |
2024/01/29 | 5,805 | 5,868 | 5,805 | 5,840 | +55 | +1% | 730,500 |
2024/01/26 | 5,794 | 5,817 | 5,752 | 5,785 | +28 | +0.5% | 813,300 |
2024/01/25 | 5,773 | 5,825 | 5,747 | 5,757 | -46 | -0.8% | 601,300 |
2024/01/24 | 5,839 | 5,873 | 5,786 | 5,803 | -108 | -1.8% | 738,100 |
2024/01/23 | 5,876 | 5,974 | 5,871 | 5,911 | +50 | +0.9% | 720,500 |
2024/01/22 | 5,836 | 5,874 | 5,816 | 5,861 | +71 | +1.2% | 504,400 |
2024/01/19 | 5,828 | 5,847 | 5,738 | 5,790 | -34 | -0.6% | 933,500 |
2024/01/18 | 5,836 | 5,872 | 5,787 | 5,824 | +16 | +0.3% | 923,300 |
2024/01/17 | 5,816 | 5,892 | 5,787 | 5,808 | +17 | +0.3% | 893,100 |
2024/01/16 | 5,864 | 5,871 | 5,774 | 5,791 | -114 | -1.9% | 770,400 |
2024/01/15 | 5,803 | 5,915 | 5,790 | 5,905 | +71 | +1.2% | 624,400 |
2024/01/12 | 5,960 | 5,977 | 5,819 | 5,834 | -34 | -0.6% | 1,389,900 |
2024/01/11 | 5,875 | 5,883 | 5,826 | 5,868 | +93 | +1.6% | 1,278,100 |
2024/01/10 | 5,707 | 5,812 | 5,679 | 5,775 | +135 | +2.4% | 1,409,200 |
2024/01/09 | 5,634 | 5,677 | 5,603 | 5,640 | +53 | +0.9% | 1,205,800 |
2024/01/05 | 5,546 | 5,612 | 5,546 | 5,587 | +96 | +1.7% | 1,164,800 |
2024/01/04 | 5,373 | 5,491 | 5,309 | 5,491 | +202 | +3.8% | 1,075,600 |
2023/12/29 | 5,284 | 5,332 | 5,244 | 5,289 | -5 | -0.1% | 1,032,600 |
2023/12/28 | 5,374 | 5,401 | 5,291 | 5,294 | -142 | -2.6% | 837,500 |
2023/12/27 | 5,418 | 5,460 | 5,390 | 5,436 | +21 | +0.4% | 1,390,800 |
2023/12/26 | 5,441 | 5,457 | 5,390 | 5,415 | -12 | -0.2% | 778,500 |
2023/12/25 | 5,417 | 5,464 | 5,415 | 5,427 | +110 | +2.1% | 846,800 |
2023/12/22 | 5,255 | 5,332 | 5,255 | 5,317 | +63 | +1.2% | 846,200 |
2023/12/21 | 5,260 | 5,290 | 5,212 | 5,254 | -19 | -0.4% | 1,185,500 |
2023/12/20 | 5,236 | 5,310 | 5,216 | 5,273 | +67 | +1.3% | 979,200 |
2023/12/19 | 5,193 | 5,236 | 5,170 | 5,206 | +22 | +0.4% | 847,100 |
2023/12/18 | 5,184 | 5,200 | 5,118 | 5,184 | -46 | -0.9% | 1,205,100 |
2023/12/15 | 5,383 | 5,385 | 5,217 | 5,230 | -190 | -3.5% | 1,997,200 |
2023/12/14 | 5,540 | 5,571 | 5,396 | 5,420 | -141 | -2.5% | 1,290,600 |
2023/12/13 | 5,652 | 5,660 | 5,560 | 5,561 | -140 | -2.5% | 942,300 |
2023/12/12 | 5,778 | 5,838 | 5,685 | 5,701 | +6 | +0.1% | 1,109,300 |
2023/12/11 | 5,653 | 5,707 | 5,617 | 5,695 | +112 | +2% | 907,600 |
2023/12/08 | 5,691 | 5,691 | 5,559 | 5,583 | -146 | -2.5% | 1,573,500 |
51~
100
件表示中 / 3277件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 645,200円 | +6.0% | +131.3% | 1.86% | 14.01倍 | 1.46倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
中外薬 | 492,400円 | -3.7% | +4.1% | 1.67% | 24.15倍 | 4.98倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 407,000円 | -1.2% | -81.3% | 4.62% | 68.66倍 | 0.90倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 154,100円 | +2.9% | +72.2% | 4.80% | 92.11倍 | 1.73倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 748,900円 | +5.5% | -12.6% | 2.14% | 13.75倍 | 1.76倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム